Sartorius Stedim Biotech SA
F:56S1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sartorius Stedim Biotech SA
F:56S1
|
FR |
|
V
|
Volkswagen AG
XHAM:VOW
|
DE |
|
Willscot Mobile Mini Holdings Corp
F:WS11
|
US |
|
C
|
Continental AG
XMUN:CON
|
DE |
|
CK Hutchison Holdings Ltd
F:2CK
|
HK |
|
S
|
Sumitomo Rubber Industries Ltd
SWB:108
|
JP |
|
Singapore Technologies Engineering Ltd
SGX:S63
|
SG |
|
S
|
Steel Authority of India Ltd
BSE:500113
|
IN |
|
C
|
Caesars Entertainment Inc
SWB:2ER
|
US |
|
P
|
Pitney Bowes Inc
DUS:PBW
|
US |
|
Douyu International Holdings Ltd
NASDAQ:DOYU
|
CN |
|
C
|
China Life Insurance Co Ltd
SWB:CHL
|
CN |
|
Croda International PLC
LSE:CRDA
|
UK |
|
C
|
Clean Power Hydrogen PLC
F:G9Z
|
UK |
|
P
|
Perk Labs Inc
CNSX:PERK
|
CA |
Wall St Price Targets
56S1 Price Targets Summary
Sartorius Stedim Biotech SA
According to Wall Street analysts, the average 1-year price target for 56S1 is 231.47 EUR with a low forecast of 208.29 EUR and a high forecast of 270.16 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 56S1's stock price target?
Price Target
231.47
EUR
According to Wall Street analysts, the average 1-year price target for 56S1 is 231.47 EUR with a low forecast of 208.29 EUR and a high forecast of 270.16 EUR.
What is the Revenue forecast for Sartorius Stedim Biotech SA?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for Sartorius Stedim Biotech SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 5 years is 13%.
What is the Operating Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Pre-Tax Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
36%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 36%.
What is the Net Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 24%.
